(Q33898374)

29 July 2017

1 reference

title

Estrogen receptor activation and tardive dyskinesia (English)

1 reference

29 July 2017

1 reference

P Turrone

1

1 reference

29 July 2017

M V Seeman

series ordinal

2

1 reference

29 July 2017

S Silvestri

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Canadian Journal of Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

45

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

288-290

1 reference

Gender differences in tardive dyskinesia: a critical review of the literature

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Tardive dyskinesia: who is at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Age affects dopamine receptor changes during chronic administration of fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Effects of estrogen on the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Estrogen replacement and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

The effect of estrogen replacement on early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Selective estrogen receptor modulators: an alternative to hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Selective oestrogen receptor modulators: potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

Menopause and the central nervous system: intervention options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500310

10.1177/070674370004500310

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference